Clinical Trial Update: Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis [Phase 2]

View source ↗

Summary

Phase 2 trial results for ferric citrate in iron-deficient anemia due to chronic kidney disease in non-dialysis patients. The study assessed management of serum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Iron Deficiency
• Iron Deficiency Anemia

Drugs mentioned

• Auryxia (ferric citrate)

Snippet

Sponsor: Keryx Biopharmaceuticals | Conditions: Iron Deficiency, Iron Deficiency Anemia | Phase 2 | Status: COMPLETED | Results posted: 2017-10-20